<DOC>
	<DOCNO>NCT00487318</DOCNO>
	<brief_summary>Hypothesis : addition fluvastatin increase cure rate standard anti-HCV therapy . Summary : This trial limit veteran Oklahoma qualify care Veterans Administration . It randomize control format include genotype 1 3 . There also pilot arm HCV carrier present screen already statin , allow stay current statin switch another statin . In way , standard therapy note pegylated interferon ribavirin give per FDA package insert .</brief_summary>
	<brief_title>Fluvastatin , Rosuvastatin Added Pegylated Interferon Ribavirin</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Not previously treat . Off alcohol marijuana 6 month HCV RNA positive HIV positive Advanced liver disease Advanced cardiopulmonary disease Chronic renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>fluvastatin</keyword>
	<keyword>hepatitis C</keyword>
	<keyword>chronic hepatitis C</keyword>
	<keyword>previously treat pegylated interferon ribavirin</keyword>
</DOC>